相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Drug Efflux Transporter Multidrug Resistance-Associated Protein 5 Affects Sensitivity of Pancreatic Cancer Cell Lines to the Nucleoside Anticancer Drug 5-Fluorouracil
Praveen K. Nambaru et al.
DRUG METABOLISM AND DISPOSITION (2011)
Advanced Phase I/II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Gemcitabine-resistant Metastatic Pancreatic Cancer
Sant P. Chawla et al.
MOLECULAR THERAPY (2010)
Interdependence of Gemcitabine Treatment, Transporter Expression, and Resistance in Human Pancreatic Carcinoma Cells
Wolfgang Hagmann et al.
NEOPLASIA (2010)
Management and prognosis of pancreatic cancer over a 30-year period
M. David et al.
BRITISH JOURNAL OF CANCER (2009)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Oncogenic Function of ATDC in Pancreatic Cancer through Wnt Pathway Activation and β-Catenin Stabilization
Lidong Wang et al.
CANCER CELL (2009)
Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
Yiwei Li et al.
CANCER RESEARCH (2009)
被撤回的出版物: 3,3′-Diindolylmethane Enhances Chemosensitivity of Multiple Chemotherapeutic Agents in Pancreatic Cancer (Retracted article. See vol. 78, pg. 5467, 2018)
Sanjeev Banerjee et al.
CANCER RESEARCH (2009)
Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
Zhiwei Wang et al.
CANCER RESEARCH (2009)
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Thiruvengadam Arumugam et al.
CANCER RESEARCH (2009)
Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma
Jennifer L. Dembinski et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Down-regulation of ZIP4 by RNA Interference Inhibits Pancreatic Cancer Growth and Increases the Survival of Nude Mice with Pancreatic Cancer Xenografts
Min Li et al.
CLINICAL CANCER RESEARCH (2009)
Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV
Assia L. Angelova et al.
CLINICAL CANCER RESEARCH (2009)
siRNA Directed Against Survivin Enhances Pancreatic Cancer Cell Gemcitabine Chemosensitivity
Wen-Song Liu et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Inhibition of γ-Secretase Activity Inhibits Tumor Progression in a Mouse Model of Pancreatic Ductal Adenocarcinoma
Ruben Plentz et al.
GASTROENTEROLOGY (2009)
Fibrinogen induces cytokine and collagen production in pancreatic stellate cells
A. Masamune et al.
GUT (2009)
Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug
Julie Guillermet-Guibert et al.
MOLECULAR CANCER THERAPEUTICS (2009)
A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development
Antonio Jimeno et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Antimetastatic Effects of Liposomal Gemcitabine and Empty Liposomes in an Orthotopic Mouse Model of Pancreatic Cancer
Ralph Graeser et al.
PANCREAS (2009)
Gemcitabine chemoresistance in pancreatic cancer: Molecular mechanisms and potential solutions
Roland Andersson et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Arsenic Trioxide in Patients With Adenocarcinoma of the Pancreas Refractory to Gemcitabine A Phase II Trial of the University of Chicago Phase II Consortium
Hedy Lee Kindler et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2008)
Pancreatic stellate cells and pancreatic cancer cells: An unholy alliance
Alain Vonlaufen et al.
CANCER RESEARCH (2008)
Cancer-associated stroma fibroblasts promote pancreatic tumor progression
Rosa F. Hwang et al.
CANCER RESEARCH (2008)
An overview of cancer multidrug resistance: a still unsolved problem
H. Lage
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Pancreatic cancer stem cells: Implications for the treatment of pancreatic cancer
Diane M. Simeone
CLINICAL CANCER RESEARCH (2008)
Nuclear Factor-κB p65/relA Silencing Induces Apoptosis and Increases Gemcitabine Effectiveness in a Subset of Pancreatic Cancer Cells
Xue Pan et al.
CLINICAL CANCER RESEARCH (2008)
Gemcitabine resistance in pancreatic cancer: Picking the key players
Michael P. Kim et al.
CLINICAL CANCER RESEARCH (2008)
RNA interference-mediated silencing of the polo-like kinase 1 gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cells
C. Yu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
NF-κB and epithelial to mesenchymal transition of cancer
Chengyin Min et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Pancreatic cancer stem cells
Cheong J. Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
In vivo characterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities
Savita Bisht et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer
Min Li et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Resistance to therapy caused by intragenic deletion in BRCA2
Stacey L. Edwards et al.
NATURE (2008)
PDX-1 acts as a potential molecular target for treatment of human pancreatic cancer
Shihe Liu et al.
PANCREAS (2008)
Aberrant hepatic artery in patients undergoing pancreaticoduodenectomy
Feng Yang et al.
PANCREATOLOGY (2008)
Notch signaling mediates hypoxia-induced tumor cell migration and invasion
Cecilia Sahlgren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Development and characterization of gemcitabine-resistant pancreatic tumor cells
Ami N. Shah et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression
Min Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Drug resistance and the solid tumor microenvironment
Olivier Tredan et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
High cancer-specific expression of mesothelin (MSLN) is attributable to an upstream enhancer containing a transcription enhancer factor-dependent MCAT motif
Tomas Hucl et al.
CANCER RESEARCH (2007)
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer
Patrick C. Hermann et al.
CELL STEM CELL (2007)
Expression of snail in pancreatic cancer promotes metastasis and chemoresistance
Tao Yin et al.
JOURNAL OF SURGICAL RESEARCH (2007)
Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer:: A randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
Richard Herrmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Identification of pancreatic cancer stem cells
Chenwei Li et al.
CANCER RESEARCH (2007)
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
Catherine A. O'Brien et al.
NATURE (2007)
HMGA1 is a determinant of cellular invasiveness and in vivo metastatic potential in pancreatic adenocarcinoma
Siong-Seng Liau et al.
CANCER RESEARCH (2006)
Expression of the human copper influx transporter 1 in normal and malignant human tissues
Alison K. Holzer et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2006)
Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer
Volker Heinemann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The phosphoinositide 3-kinase/Akt pathway: A new target in human renal cell carcinoma therapy
Carole Sourbier et al.
CANCER RESEARCH (2006)
Major combined electrolyte deficiency during therapy with low-dose Cisplatin, 5-Fluorouracil and Interferon alpha: report on several cases and review of the literature [ISRCTN62866759]
Katrin Hoffmann et al.
BMC CANCER (2006)
Raltitrexed-eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer
M Reni et al.
BRITISH JOURNAL OF CANCER (2006)
Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study
A Demols et al.
BRITISH JOURNAL OF CANCER (2006)
New target therapies in advanced pancreatic cancer
S. Cascinu et al.
ANNALS OF ONCOLOGY (2006)
Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase
J Zhou et al.
CANCER RESEARCH (2006)
Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis
R Hassan et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2005)
Phase II trial of bevacizurnab plus gemcitabine in patients with advanced pancreatic cancer
HL Kindler et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
S100P promotes pancreatic cancer growth, survival, and invasion
T Arumugam et al.
CLINICAL CANCER RESEARCH (2005)
Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma
J König et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer:: Results of a GERCOR and GISCAD phase III trial
C Louvet et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Targeting apoptosis pathways in cancer therapy
IM Ghobrial et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Inhibition of AKT abrogates chemotherapy-induced NF-κB survival mechanisms:: Implications for therapy in pancreatic cancer
BN Fahy et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2004)
被撤回的出版物: CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells (Retracted article. See FEB, 2023)
MS Duxbury et al.
ONCOGENE (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
siRNA directed against c-Src enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivity
MS Duxbury et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2004)
The MRP family of drug efflux pumps
GD Kruh et al.
ONCOGENE (2003)
Notch mediates TGFα-induced changes in epithelial differentiation during pancreatic tumorigenesis
Y Miyamoto et al.
CANCER CELL (2003)
Incidence, mechanism and prognostic value of activated AKT in pancreas cancer
MG Schlieman et al.
BRITISH JOURNAL OF CANCER (2003)
Nuclear factor-kappa B and cancer: its role in prevention and therapy
AC Bharti et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297
JD Berlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine)
AM Bergman et al.
DRUG RESISTANCE UPDATES (2002)
Overview: ABC transporters and human disease
MM Gottesman et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2001)
Exploring the structure and function of the P-glycoprotein multidrug transporter using fluorescence spectroscopic tools
FJ Sharom et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2001)
分享论文
